Congress targets another drugmaker for ‘unconscionable’ prices

Two members of Congress on Monday demanded to know why an Illinois company plans to charge $89,000 per year for a muscular dystrophy drug, even though it’s been widely available overseas for just $1,000. Sen. Bernard Sanders, Vermont independent, and Rep. Elijah Cummings, Maryland Democrat, said the price is “unconscionable,” making Marathon Pharmaceuticals the latest drugmaker…